Insiders · MIRM

Christopher Peetz

Chief Executive Officer, Director at Mirum Pharmaceuticals, Inc. (MIRM)

Christopher Peetz has filed 55 insider reports with the SEC since May 2021, as chief Executive Officer and director at Mirum Pharmaceuticals, Inc. (MIRM), director at Arcutis Biotherapeutics, Inc. (ARQT) and director at Alpine Immune Sciences, Inc. (ALPN). In the last 12 months Christopher Peetz sold $18.1M of stock on the open market. On November 4, 2026 Christopher Peetz filed a Form 144 notice and plans to sell 20,000 MIRM shares (~$1.8M). In the latest filing, on November 5, 2026, Christopher Peetz sold 20,000 shares of Mirum Pharmaceuticals, Inc. (MIRM) for $1.8M at an average of $90.00.

Planned sale (Form 144)

  • Christopher Peetz plans to sell 20,000 MIRM shares (~$1.8M), around Nov 4, 2026. Notice filed Nov 4, 2026.

A Form 144 is a notice of a proposed sale, not a trade. The sale itself shows up in a later Form 4.

Filings
55
Companies
3
Bought on market
$120K
Sold on market
$27.6M

Companies where Christopher Peetz is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Mirum Pharmaceuticals, Inc. logo
MIRM
Mirum Pharmaceuticals, Inc.
Chief Executive Officer, Director206,637$101K$27.6M$14.40$92.49+542%Nov 5, 2026
Arcutis Biotherapeutics, Inc. logo
ARQT
Arcutis Biotherapeutics, Inc.
Directorsince July 20264,315$27.61Jul 17, 2026
Alpine Immune Sciences, Inc. logo
ALPN
Alpine Immune Sciences, Inc.
Director$19.3K$10.17May 21, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with Christopher Peetz.

Compare Christopher Peetz with

Other insiders at the same companies

Questions about Christopher Peetz

What is Christopher Peetz's role at Mirum Pharmaceuticals, Inc.?
Christopher Peetz reports to the SEC as chief Executive Officer and director at Mirum Pharmaceuticals, Inc. (MIRM), according to the latest filing on November 5, 2026. Christopher Peetz has also filed as director at Arcutis Biotherapeutics, Inc. (ARQT) and director at Alpine Immune Sciences, Inc. (ALPN).
How many shares does Christopher Peetz own?
After the latest filing that states it, Christopher Peetz directly owned 206,637 shares of Mirum Pharmaceuticals, Inc. (MIRM) and 4,315 shares of Arcutis Biotherapeutics, Inc. (ARQT). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Christopher Peetz bought or sold stock recently?
The most recent open-market purchase was on November 24, 2021: bought 7,000 shares of Mirum Pharmaceuticals, Inc. (MIRM) for $101K at an average of $14.40. The most recent open-market sale was on November 4, 2026: sold 20,000 shares of Mirum Pharmaceuticals, Inc. (MIRM) for $1.8M at an average of $90.00.
How do I get alerts when Christopher Peetz files?
Follow Christopher Peetz on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Christopher Peetz filed 4 times in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Christopher Peetz (SEC CIK 0001614740). Totals count each trade once, skipping amendments whose original is on file, from May 12, 2021 on. View on SEC EDGAR